RIBESKIN’s Three Days of Connection, Conversation and Insights
From January 29~31, 2026, RIBESKIN proudly participated in IMCAS Paris 2026, one of the world’s most recognized congresses for medical aesthetics and anti-aging medicine. Hosted in Paris, France and attended by global professionals across dermatology, aesthetic medicine, and device-based treatments, IMCAS is where clinical insights meet emerging trends, and where meaningful partnerships begin.
For our teams, IMCAS Paris 2026 was more than an exhibition. It was a valuable opportunity to share our product philosophy, listen closely to practitioner needs, and strengthen relationships with partners from different regions. Over three high-energy days, we were grateful to connect with an international audience and leave Paris with renewed momentum for the year ahead.
A Booth that Sparked Real Conversations
Throughout the event, the RIBESKIN & TURTLEPIN booth remained active with steady traffic and engaged visitors. We were proud to build more than 100 new connections, meeting medical aesthetic practitioners, distributors, clinic owners, and industry professionals from across the globe.
What stood out most wasn’t simply the number of people who visited, it was the depth of conversation. Many attendees stayed to ask detailed questions, compare approaches, and discuss how different lines could align with real clinic workflows. These moments matter, because strong growth in the aesthetic market depends on practical education, credible communication, and a clear understanding of what professionals need in the field.
View this post on Instagram
Introducing RIBESKIN’s Key Lines at IMCAS
At IMCAS Paris 2026, RIBESKIN showcased several of its main lines, including Betterfill, Hairlopecia, GPEEL, Dr.MAL, and 365 Pro Care. Each line attracted attention for different reasons, but overall we saw a consistent theme: professionals are looking for solutions that can be explained clearly, positioned responsibly, and integrated thoughtfully into treatment routines.
Betterfill generated strong interest among visitors exploring professional aesthetic product lineups and clinic-based programs.
Hairlopecia encouraged meaningful conversations with practitioners focused on scalp care routines and program-oriented patient management.
G-PEEL drew interest for its exfoliation-focused concept and for discussions around how to structure treatment flow in practice.
Dr.MAL became a conversation starter for professionals interested in PDT-related approaches and supportive care routines.
365 Pro Care consistently resonated with attendees who emphasized the importance of recovery support and patient experience after procedures.
We were especially encouraged to see visitors not only reacting to products, but also asking about real-world use: how programs are built, what patients typically request, and what kind of post-treatment support improves satisfaction and compliance.
Five KOL Interview at our Booth
Another highlight of IMCAS Paris 2026 was hosting five KOL interviews at our booth. These interviews allowed us to capture real practitioner insights, what is changing in clinical settings, what patients are asking for, and how practitioners are adapting protocols as trends evolve.
More importantly, the interviews created space for genuine exchange. Listening to KOL feedback helps us refine how we communicate, how we support partners, and how we develop educational materials that are relevant across markets. We’re excited to share these interviews and transform the insights into practical content that supports clinics, professionals, and distributors worldwide.
View this post on Instagram
Reuniting With Global Partners and Friends
IMCAS is always a valuable place to meet new contacts, but it’s also a meaningful place to reconnect. This year, we were happy to spend time with many of our global partners and longtime friends, sharing updates, discussing plans for 2026, and building alignment for future collaboration.
These conversations, sometimes just a quick greeting between sessions, sometimes a longer discussion at the booth, are the foundation of long-term partnership. For RIBESKIN and TURTLEPIN, global growth is built not only on products, but on trust, consistency, and shared goals.
Thank You, IMCAS Paris | See You Next Time
IMCAS Paris 2026 was a memorable and energizing experience for both RIBESKIN and TURTLEPIN. From building new relationships and showcasing our core lines, to capturing KOL interviews and achieving sold-out results, the event marked a strong step forward.
To everyone who visited our booth and shared their time, feedback, and interest, thank you. We look forward to continuing the conversations started in Paris and creating new opportunities together throughout 2026.
View this post on Instagram
Our Next Stop: Monaco!
This definitely was not our last time meeting, there will be many more opportunities ahead.
Next, we’ll be joining AMWC Congress in Monaco during March 26-28, bringing RIBESKIN with us, and we’re already preparing to create even more exciting moments there. We can’t wait to connect again, share what’s next, and keep building something great together.
Stay connected as we continue to innovate, inspire, and elevate the world of aesthetic medicine.
For Aesthetic Medicine:
Discover RIBESKIN’s aesthetic medicine treatments here, specially developed for dermatology and aesthetic clinics across the world.
If you are a dermatologist, aesthetic doctor, plastic surgeon, cosmetologist or distributor of aesthetic products, get in touch with us here.
For Professional Beauty:
Discover RIBESKIN’s professional beauty treatments here, specially developed for beauty salons and spas across the world.
If you are an aesthetician/ esthetician, beauty therapist or distributor of professional beauty products, get in touch with us here.
